Potential Biomarkers for Liver Cancer Diagnosis Based on Multi-Omics Strategy

Liver cancer is the fourth leading cause of cancer-related death worldwide. Hepatocellular carcinoma (HCC) accounts for about 85%-90% of all primary liver malignancies. However, only 20-30% of HCC patients are eligible for curative therapy mainly due to the lack of early-detection strategies, highli...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fanghua, Wang, Junming, Wu, Yingcheng, Gao, Qiang, Zhang, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851237/
https://www.ncbi.nlm.nih.gov/pubmed/35186756
http://dx.doi.org/10.3389/fonc.2022.822449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851237/
https://www.ncbi.nlm.nih.gov/pubmed/35186756
http://dx.doi.org/10.3389/fonc.2022.822449

Ejemplares similares